SCHEMBL19021519

SCHEMBL19021519

CC1CCC(NC(=O)c2cnc3cc(OC(F)F)c(Cl)cc3c2)C1

nearest known ligand 0.52

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ HPGDS O60760 20/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19021516 0.94 HPGDS (0.56) HPGDS
SCHEMBL23731339 0.93 HPGDS (0.50) HPGDS
SCHEMBL19021455 0.87 HPGDS (0.54) HPGDS
SCHEMBL19019768 0.86 HPGDS (0.54) HPGDS
SCHEMBL18987514 0.86 HPGDS (0.53) HPGDS
SCHEMBL18988534 0.86 HPGDS (0.54) HPGDS
SCHEMBL18988533 0.86 HPGDS (0.54) HPGDS
SCHEMBL18988091 0.86 HPGDS (0.54) HPGDS
SCHEMBL23794264 0.86 HPGDS (0.54) HPGDS
SCHEMBL23794265 0.86 HPGDS (0.54) HPGDS

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3390384-B1 QUINOLINE-3-CARBOXAMIDES AS H-PGDS INHIBITORS ASTEX THERAPEUTICS LTD (GB) 2021-09-15 — — EP disclosed
WO-2017103851-A1 QUINOLINE-3-CARBOXAMIDES AS H-PGDS INHIBITORS ASTEX THERAPEUTICS LIMITED (GB) 2017-06-22 — — WO disclosed
Send feedback